Patent application number | Description | Published |
20090060815 | Silylated carbon nanotubes and methods of making same - The invention provides adducts comprising a carbon nanotube with covalently attached silane moieties, and methods of making such adducts. Examples of silane moieties include trimethoxysilane; hexaphenyldisilane; silylphosphine; 1,1,1,3,5,5,5-heptamethyltrisiloxane; polydimethylsiloxane, poly(N-bromobenzene-1,3-disulfonamide); N,N,N′,N′-tetrabromobenzene-1,3-disulfonamide; hexamethyldisilazane (HMDS); chlorotrimethylsilane (TMCS); trichloromethylsilane (TCMS); an alkyl(alkylamino)silane; a tri(alkoxy)silane; tert-butyldimethylsilane; monochloroaminosilane; dichloroaminosilane; trichloroaminosilane; and dimethylaminosilane. | 03-05-2009 |
20090090886 | Single-crystalline hematite rhombohedra and magnetic nanocomposites of iron and magnetite and methods of making same - The present invention relates to nanostructures, in particular to hematite rhombohedra and iron/magnetite nanocomposites, and methods of making same. | 04-09-2009 |
20090308753 | Methods for controlling silica deposition onto carbon nanotube surfaces - The invention provides a method of controlling the rate of noncovalent silica deposition onto at least one carbon nanotube. The method comprises (a) providing a one chamber electrochemical cell comprising a working electrode comprising at least one carbon nanotube; a reference electrode; a counter electrode; supporting electrolytes; and a reagent solution, wherein the reagent solution comprises a precursor of silica; and (b) applying a selected negative potential to the working electrode, wherein the rate of silica deposition onto the at least one carbon nanotube increases as the potential becomes more negative. | 12-17-2009 |
20100021471 | CARBON NANOTUBE-BASED DRUG DELIVERY SYSTEMS AND METHODS OF MAKING SAME - The present invention includes a conjugates comprising a carbon nanotube with at least one covalently attached recognition module, and at least one covalently attached pharmaceutical compound or a precursor of the pharmaceutical compound, | 01-28-2010 |
20100129286 | Methods of controlling the morphology of perovskite submicron-sized particles - The present invention includes a method of making a plurality of nanoparticles comprising single crystalline spherical BaZrO | 05-27-2010 |
20100278720 | Methods of Making Binary Metal Oxide Nanostructures and Methods of Controlling Morphology of Same - The present invention includes a method of producing a crystalline metal oxide nanostructure. The method comprises providing a metal salt solution and providing a basic solution; placing a porous membrane between the metal salt solution and the basic solution, wherein metal cations of the metal salt solution and hydroxide ions of the basic solution react, thereby producing a crystalline metal oxide nanostructure. | 11-04-2010 |
20130084210 | SURFACTANTLESS METALLIC NANOSTRUCTURES AND METHOD FOR SYNTHESIZING SAME - Disclosed are nanowires and a nanowire synthesis method, with the nanowires synthesized by adding first and second solutions into a vessel containing a porous template, the first solution added on one side of the porous template and the second solution added on another side of the porous template. The first solution contains a metal reagent comprising at least one of a transition metal, an actinide and a lanthanide metal, and the second solution contains a reducing agent. | 04-04-2013 |
20130102458 | Titanate and titania nanostructures and nanostructure assemblies, and methods of making same - The invention relates to nanomaterials and assemblies including, a micrometer-scale spherical aggregate comprising: a plurality of one-dimensional nanostructures comprising titanium and oxygen, wherein the one-dimensional nanostructures radiate from a hollow central core thereby forming a spherical aggregate. | 04-25-2013 |
20140290436 | SURFACTANTLESS BIMETALLIC NANOSTRUCTURES AND METHOD FOR SYNTHESIZING SAME - A bimetallic nanowire synthesis method is provided. The method includes adding first and second solutions into a vessel containing a porous template with the first solution containing first and second reagents added on one side of the porous template and the second solution added on an opposite side of the porous template. The first reagent includes a first salt of at least one of a transition metal, an actinide metal and a lanthanide metal. The second reagent includes a second salt of at least one of a transition metal, an actinide metal and a lanthanide metal. The second solution contains a reducing agent. | 10-02-2014 |